WHC est encore en dévelopement. Lisez ceci pour comprendre notre approche.
depiction of PHEDXBVPIONUQT-UHFFFAOYSA-N.svg
tripsit

pma

Vérifier sur tripsit

psychonaut

PMA

Vérifier sur psychonaut

pubchem

Phorbol 12-myristate...

Vérifier sur pubchem

druglab

PMA

Vérifier sur druglab

drugmap

phorbol 12-myristate...

Vérifier sur drugmap

Data

InChI: InChI=1S/C36H56O8/c1-7-8-9-10-11-12-13-14-15-16-17-18-29(39)43-32-24(3)35(42)27(30-33(5,6)36(30,32)44-25(4)38)20-26(22-37)21-34(41)28(35)19-23(2)31(34)40/h19-20,24,27-28,30,32,37,41-42H,7-18,21-22H2,1-6H3

Synonymes: DTXSID5023798,Myristic acid, 9-ester with 1,1aalpha,1bbeta,4,4a,7aalpha,7b,8,9,9a-decahydro-4abeta,7balpha,9beta,9aalpha-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8alpha-tetramethyl-5H-cyclopropa(3,4)benz(1,2-e)azulen-5-one 9a-acetate, (+)-,Phorbol ester,Bio2_000352,phorbol 13-acetate 12-myristate,AKOS024418767,DivK1c_006897,HY-18739,Spectrum4_000889,Phorbol monoacetate monomyristate,SpecPlus_000801,TPA (phorbol derivative),Bio1_000789,N2060,SCHEMBL115567,TPA,KBio3_000708,Spectrum2_001911,CHEMBL279115,HB0502,Spectrum5_001855,NI40JAQ945,(1S,2S,6R,10S,11R,13S,14R,15R)-13-(acetyloxy)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0^{2,6}.0^{11,13}]pentadeca-3,8-dien-14-yl tetradecanoate,SPECTRUM330004,KBio2_000364,12-O-Tetradecanoyl phorbol acetate,Bio1_000300,Myristic acid, 9-ester with 1,1aalpha,1bbeta,4,4a,7aalpha,7b,8,9,9a-decahydro-4abeta,7balpha,9beta,9aalpha-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8alpha-tetramethyl-5H-cyclopropa[3,4]benz[1,2-e]azulen-5,Phorbol 12-myristate 13-acetate (PMA),4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha)]-,NSC 262244,GTPL2341,KBioGR_001298,(1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(Acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl tetradecanoate, tetradecanoyl-beta-phorbol acetate,NCGC00161633-04,Phorbol 12-tetradecanoate 13-acetate,4-.beta.-Phorbol 12-myristate 13-OAc,Phorbol 12-myristate 13-acetate diester,5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one, 1,1a-beta,1b-alpha,4,4a,7a-beta,7b,8,9,9a-decahydro-4a-alpha,7b-beta,9-alpha,9a-beta-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-beta-tetramethyl-, 9a-acetate 9-myristate,Phorbol-12-myristate-13-acetate - CAS 16561-29-8,1H-Cyclopropa[3,4]benz[1,2-e]azulene, tetradecanoic acid deriv.,Phorbol-myristate acetate,KBio2_002932,CHEBI:37537,UNII-NI40JAQ945,Tetradecanoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9, 9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester, (1aR-(1aa,1bb,4ab,7aa,7ba, 8a,9b,9aa))-,NSC-262644,Pma (phorbol ester),BDBM50099066,HMS3403D05,NSC262244,Tpa (phorbol ester),Cocarcinogen C3,SPBio_001902,HSDB 3542,Q416716,Tetradisant-[[4-(1, 1-oxideomega.-[2-(dodecylthio)ethoxy]-,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-, mixt. with denatured calf thymus DNAA, (2S-cis)-, compd. with sulfinylbis[methane] (2:1)2S-cis)-1:9),MFCD00036736,Cocarcinogen A1,Tetradecanoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester, [1aR-(1aalpha,1bbeta,,BRN 2407201,Phorbol myristate acetate,12-o-tetradecanoyl phorbol-13-acetate,11016-13-0,12-Tetradecanoylphorbol 13-acetate,BCBcMAP01_000182,Bio2_000832,5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one, 1,1a-beta,1b-alpha,4,4a,7a-beta,7b,8,9,9a-decahydro-4a-alpha,7b-beta,9-alpha,9a-beta-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-beta-tetramethyl-, 9a-acetate 9-m,NSC262644,[acetoxy-dihydroxy-(hydroxymethyl)-tetramethyl-oxo-[?]yl] tetradecanoate,Bio1_001278,12-o-tetradecanoylphorbol-13-acetate (tpa),12-o-tetradecanoyl-phorbol-13-acetate,13-O-Acetylphorbol 12-myristate,W-201494,EX-A6920,beta-Phorbol 12-myristate 13-acetate,BRD-K68552125-001-03-8,CCRIS 716,12-o-Tetradekanoylphorbol-13-acetat,UPCMLD-DP069,UPCMLD-DP069:002,ZINC8214783,Myristic acid, 9-ester with 1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-4a-beta,7b-alpha,9-beta,9a-alpha-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-alpha-tetramethyl-5H-cyclopropa(3,4)benz(1,2-e)azulen-5-one, 9a-acetate,PMA,(1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-acetoxy-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-1H-cyclopropa[3,4]benzo[1,2-e]azulen-9-yl tetradecanoate,PHORBOL 12-MYRISTATE 13-ACETATE DIESTER [MI],s7791,FS-4842,tetradecanoic acid, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9,PMA, for use in molecular biology applications, >=99% (TLC),12-O-tetradecanoyl phorbol-13-acetate;Cocarcinogen A1; Cocarcinogen C3,PMA (tumor promoter),Phorbol-12-myristate 13-acetate,Factor A1,HMS1792D05,CCG-39863,NSC-262244,C05151,phorbol12-myristate13-acetate,NCGC00161633-01,KBioSS_000364,phorbol-12-myristate-13-acetate,12-O-Tetradecanoylphorbol-13-acetate,P1585,HMS1990D05,Phorbol 12-myristate 13-acetate, synthetic, >=98.0% (TLC),AC-33957,KBio1_001841,12-Tetradecanoylphorbol-13-acetate,MolMap_000041,(1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(Acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a ,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl tetradecanoate,KBioGR_000364,NCGC00161633-05,NSC626496,Phorbol 12-myristate 13-acetate, >=99% (TLC), film or powder,BRD-K68552125-001-04-6,KBio3_000707,[(1S,2S,6R,10S,11R,13S,14R,15R)-13-acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradecanoate,yristate,CS-6053,12-Tetradecanoylphorbol 13-monoacetate,NSC-626496,12-O-TETRADECANOYLPHORBOL-13-ACETATE [HSDB],LMPR0104330002,16561-29-8,13-Tetradecanoylphorbol acetate,12-O-Tetradekanoylphorbol-13-acetat [German],Tetradecanoic acid, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester,Pentahydroxy-tigliadienone-monoacetate(c)monomyristate(b),IDI1_002107,Phorbol acetate, myristate,BIDD:PXR0145,BSPBio_001024,UPCMLD-DP069:001,tetradecanoyl-beta-phorbol acetate, 12-O-tetradecanoylphorbol-13-acetate,PHORBOL-12-TETRADECANOYL-13-ACETATE,Phorbol 13 Acetate 12 Myristate,12-O-Tetradecanoylphorbol 13-acetate,KBio2_005500,CBiol_002014,Tetradecanoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester, (1aR-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha))-,4beta-Phorbol 12-myristate 13-acetate,HMS1362D05,Phorbol 12-myristate 13-acetate,Tetradecanoylphorbol acetate,4beta-Phorbol-12-myristate-13-acetate,Factor A1 (croton oil)


Estimated data

Solubility: -6.198 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 26.5% (prediction based on www.mdpi.com)

Similitudes

Voici une série de comparaisons visant à comprendre les propriétés de ce composé. Ce site est encore très expérimental et fait l'objet d'un développement actif. Veuillez vous référer à notre série d'articles d'articles pour bien comprendre notre approche et ses limites. Ces informations sont données à titre indicatif et ne doivent pas être interprétées comme des conseils médicaux.